drugset / Trial / NCT02285413
Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients
RandomizedSingle-groupOpen-labelTreatment
Summary
This is an exploratory study and the primary objective is the immunogenicity and feasibility of combined chemotherapy-DC vaccination. The secondary objectives are the toxicity and clinical efficacy. This study will provide important data on the immunological efficacy of DC immunochemotherapy.
Timeline
- Start
- 2011-02
- Primary completion
- 2015-10
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 50 mg/m2 | — |
| Subject | DCVax-L | Vaccine | — | Intravenous |